Depression
FDA Panel Does Not Recommend Astra’s Seroquel XR To Treat Anxiety
04/13/2009
A Food and Drug Administration panel didn´t recomended AZeneca Plc blockbuster drug Seroquel XR (quetiapine) to treat anxiety although it received support from experts, if added to other drugs, to find a suitable combination to alleviate depression.
Fabry Disease
Shire Plc: Enzyme Therapy With Replagal Drug Slows Progression Of Fabry
04/13/2009
Shire´s enzyme therapy drug Replagal (agalsidase alfa), indicated to treat Fabry’s disease, is seeking approval for early use as it showed that slows progression for this specific condition
J&J Does Not Have Intentions To Join The “biosimilars” Market
04/13/2009
Even though many competitors already participate into the biosimilars segment (generic-like versions of biologics drugs) the gigantic American drug maker Johnson & Johnson denied plans to participate as well (just for now).
Wolters Kluwer Health Study
Study Shows That More Americans Do Not Buy Already Prescribed-drugs For Economic Reasons
04/13/2009
Health-information company Wolters Kluwer Health, revealed that more Americans are not buying already prescribed-drugs due to economic reasons. The current recession is having an unusually negative impact and it also hit the generics segments. The health-insurance companies main role.
- BLOG
- VIDEOS
- NM Extra
